Boston Scientific Corporation
BSX · NYSE
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | – | $795 | $672 | $562 |
| Dep. & Amort. | – | $336 | $325 | $348 |
| Deferred Tax | – | -$90 | $41 | -$80 |
| Stock-Based Comp. | – | $75 | $74 | $69 |
| Change in WC | – | $233 | -$678 | $324 |
| Other Non-Cash | – | -$63 | $107 | $233 |
| Operating Cash Flow | – | $1,286 | $541 | $1,456 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | – | -$157 | -$187 | -$277 |
| Net Acquisitions | – | -$1,009 | -$239 | -$3,418 |
| Inv. Purchases | – | $0 | $0 | $0 |
| Inv. Sales/Matur. | – | $0 | $0 | $0 |
| Other Inv. Act. | – | $40 | -$74 | -$9 |
| Investing Cash Flow | – | -$1,126 | -$500 | -$3,704 |
| Financing Activities | – | – | – | – |
| Debt Repay. | – | -$314 | $247 | $189 |
| Stock Issued | – | $32 | $115 | $28 |
| Stock Repurch. | – | $0 | $0 | $0 |
| Dividends Paid | – | $0 | $0 | $0 |
| Other Fin. Act. | – | -$58 | -$129 | -$3 |
| Financing Cash Flow | – | -$340 | $233 | $214 |
| Forex Effect | – | $2 | $39 | -$9 |
| Net Chg. in Cash | – | -$178 | $313 | -$2,043 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | – | $919 | $606 | $2,649 |
| End Cash | – | $741 | $919 | $606 |
| Free Cash Flow | – | $1,096 | $354 | $1,163 |